In our experiments, both AMPK signaling and Retrograde endocannabinoid signaling are enriched, the latter having been associated with neuron diseases [34] but its implication in NAFLD yet to be investigated. This evidence concerns the gene PRKAA2 and metabolic dysfunction-associated steatotic liver disease.